top-selling glp-1 medications in the u.s. 2025 New Health Consumer Mindset and Wallet: From GLP-1s to Trading Up for Health & Longevity GLP-1 Shortage = Over -

Post-antibiotic use Here is a scenario that catches many people off guard

Related Reading Fridays Zepbound Hims Zepbound Form Health Zepbound Brello Zepbound Pricing and availability current as of June 2026

Perhaps for this reason, clinical trials of additional short-acting incretin mimetics, such as lixisenatide, are ongoing, with the aim of combining these drugs with basal insulin

Research by Su and colleagues suggests that genetic variations influence how individuals respond to GLP-1 medications in terms of both weight loss and side effects

New retatrutide data raise the ceiling for what next-generation metabolic drugs may eventually achieve, but investigational results should not be confused with an available treatment plan

Roches company sales grew by 10%, driven primarily by the continued growth of Vabysmo